Chromatin and nuclear architecture in the nervous system

Trends in Neurosciences

Volumn 31, Issue 7, 2008, Pages 343-352

  Takizawa, Takumi ^a,b   Meshorer, Eran ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE INHIBITOR;

CHROMATIN; CHROMATIN STRUCTURE; CHROMOSOME ANALYSIS; DEMETHYLATION; GENE LOCUS; NERVE CELL; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL NUCLEUS; CHROMATIN; HUMANS; NERVOUS SYSTEM; NEURONS;

EID: 45849146938     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2008.03.005     Document Type: Review

References (107)

1. Misteli T. Concepts in nuclear architecture. Bioessays 27 (2005) 477-487
2. Ching R.W., et al. PML bodies: a meeting place for genomic loci?. J. Cell Sci. 118 (2005) 847-854
3. Robinson P.J., and Rhodes D. Structure of the '30 nm' chromatin fibre: a key role for the linker histone. Curr. Opin. Struct. Biol. 16 (2006) 336-343
4. Cheutin T., et al. Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science 299 (2003) 721-725
5. Misteli T. Protein dynamics: implications for nuclear architecture and gene expression. Science 291 (2001) 843-847
6. Misteli T., et al. Dynamic binding of histone H1 to chromatin in living cells. Nature 408 (2000) 877-881
7. Phair R.D., and Misteli T. High mobility of proteins in the mammalian cell nucleus. Nature 404 (2000) 604-609
8. Cremer T., et al. Analysis of chromosome positions in the interphase nucleus of Chinese hamster cells by laser-UV-microirradiation experiments. Hum. Genet. 62 (1982) 201-209
9. Lande-Diner L., and Cedar H. Silence of the genes - mechanisms of long-term repression. Nat. Rev. Genet. 6 (2005) 648-654
10. Manuelidis L. Different central nervous system cell types display distinct and nonrandom arrangements of satellite DNA sequences. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 3123-3127
11. Manuelidis L. Indications of centromere movement during interphase and differentiation. Ann. N. Y. Acad. Sci. 450 (1985) 205-221
12. Manuelidis L. A view of interphase chromosomes. Science 250 (1990) 1533-1540
13. Solovei I., et al. Positional changes of pericentromeric heterochromatin and nucleoli in postmitotic Purkinje cells during murine cerebellum development. Cytogenet. Genome Res. 105 (2004) 302-310
14. Casafont I., et al. Nuclear organization and dynamics of transcription sites in rat sensory ganglia neurons detected by incorporation of 5′-fluorouridine into nascent RNA. Neuroscience 140 (2006) 453-462
15. Pena E., et al. Neuronal body size correlates with the number of nucleoli and Cajal bodies, and with the organization of the splicing machinery in rat trigeminal ganglion neurons. J. Comp. Neurol. 430 (2001) 250-263
16. Janevski J., et al. Changes in morphology and spatial position of coiled bodies during NGF-induced neuronal differentiation of PC12 cells. J. Histochem. Cytochem. 45 (1997) 1523-1531
17. Santama N., et al. Neuronal differentiation in the rat hippocampus involves a stage-specific reorganization of subnuclear structure both in vivo and in vitro. Eur. J. Neurosci. 8 (1996) 892-905
18. Aoto T., et al. Nuclear and chromatin reorganization in the MHC-Oct3/4 locus at developmental phases of embryonic stem cell differentiation. Dev. Biol. 298 (2006) 354-367
19. Villagra N.T., et al. PML bodies in reactive sensory ganglion neurons of the Guillain-Barre syndrome. Neurobiol. Dis. 16 (2004) 158-168
20. Jordan B.A., et al. Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers and protein synthesis in neurons. Nat. Neurosci. 10 (2007) 427-435
21. Meshorer E., et al. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell 10 (2006) 105-116
22. Meshorer E., and Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat. Rev. Mol. Cell Biol. 7 (2006) 540-546
23. Ong W.Y., and Garey L.J. Ultrastructural characteristics of human adult and infant cerebral cortical neurons. J. Anat. 175 (1991) 79-104
24. Sarkander H.I., and Uthoff C.G. Comparison of the number of RNA initiation sites in rat brain fractions enriched in neuronal or glial nuclei. FEBS Lett. 72 (1976) 53-56
25. Sato S., et al. Transcription and motoneuron size. J. Neurochem. 63 (1994) 1609-1615
26. Sperling L., and Weiss M.C. Chromatin repeat length correlates with phenotypic expression in hepatoma cells, their dedifferentiated variants, and somatic hybrids. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 3412-3416
27. Ermini M., and Kuenzle C.C. The chromatin repeat length of cortical neurons shortens during early postnatal development. FEBS Lett. 90 (1978) 167-172
28. Jaeger A.W., and Kuenzle C.C. The chromatin repeat length of brain cortex and cerebellar neurons changes concomitant with terminal differentiation. EMBO J. 1 (1982) 811-816
29. Berkowitz E.M., et al. Chromatin structure in neuronal and neuroglial cell nuclei as a function of age. J. Neurochem. 41 (1983) 516-523
30. Lewis P.N., et al. Changes in chromatin structure associated with Alzheimer's disease. J. Neurochem. 37 (1981) 1193-1202
31. Lukiw W.J., et al. Chromatin structure and gene expression in Alzheimer's disease. Brain Res. Mol. Brain Res. 7 (1990) 227-233
32. Martou G., and De Boni U. Nuclear topology of murine, cerebellar Purkinje neurons: changes as a function of development. Exp. Cell Res. 256 (2000) 131-139
33. Vadakkan K.I., et al. Cell-type specific proximity of centromeric domains of one homologue each of chromosomes 2 and 11 in nuclei of cerebellar Purkinje neurons. Chromosoma 115 (2006) 395-402
34. Borden J., and Manuelidis L. Movement of the X chromosome in epilepsy. Science 242 (1988) 1687-1691
35. Takizawa T., et al. Allele-specific nuclear positioning of the monoallelically expressed astrocyte marker GFAP. Genes Dev. 22 (2008) 489-498
36. Nielsen J.A., et al. Nuclear organization in differentiating oligodendrocytes. J. Cell Sci. 115 (2002) 4071-4079
37. Reddy K.L., et al. Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature 452 (2008) 243-247
38. Finlan L.E., et al. Recruitment to the nuclear periphery can alter expression of genes in human cells. PLoS Genet. 4 (2008) e1000039
39. Kumaran R.I., and Spector D.L. A genetic locus targeted to the nuclear periphery in living cells maintains its transcriptional competence. J. Cell Biol. 180 (2008) 51-65
40. Ling J.Q., et al. CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science 312 (2006) 269-272
41. Thatcher K.N., et al. Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples. Hum. Mol. Genet. 14 (2005) 785-797
42. Dong E., et al. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12578-12583
43. Dong E., et al. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4676-4681
44. Weaver I.C., et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 7 (2004) 847-854
45. Tsankova N.M., et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9 (2006) 519-525
46. Renthal W., et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56 (2007) 517-529
47. Meshorer E., et al. Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295 (2002) 508-512
48. Meshorer E., and Soreq H. Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci. 29 (2006) 216-224
49. Meshorer E., et al. SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA. Mol. Psychiatry 10 (2005) 985-997
50. Cheung P., et al. Signaling to chromatin through histone modifications. Cell 103 (2000) 263-271
51. Berger S.L. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12 (2002) 142-148
52. Iizuka M., and Smith M.M. Functional consequences of histone modifications. Curr. Opin. Genet. Dev. 13 (2003) 154-160
53. Thomas T., et al. Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development. Development 127 (2000) 2537-2548
54. Etchegaray J.P., et al. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature 421 (2003) 177-182
55. Swank M.W., and Sweatt J.D. Increased histone acetyltransferase and lysine acetyltransferase activity and biphasic activation of the ERK/RSK cascade in insular cortex during novel taste learning. J. Neurosci. 21 (2001) 3383-3391
56. Fischer A., et al. Recovery of learning and memory is associated with chromatin remodelling. Nature 447 (2007) 178-182
57. Rouaux C., et al. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J. 22 (2003) 6537-6549
58. Kontopoulos E., et al. α-Synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum. Mol. Genet. 15 (2006) 3012-3023
59. Hong E.J., et al. Transcriptional control of cognitive development. Curr. Opin. Neurobiol. 15 (2005) 21-28
60. Marin-Husstege M., et al. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J. Neurosci. 22 (2002) 10333-10345
61. Ajamian F., et al. Upregulation of class II histone deacetylases mRNA during neural differentiation of cultured rat hippocampal progenitor cells. Neurosci. Lett. 346 (2003) 57-60
62. Hsieh J., et al. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16659-16664
63. Boutillier A.L., et al. Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis. J. Neurochem. 84 (2003) 814-828
64. Bolger T.A., and Yao T.P. Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J. Neurosci. 25 (2005) 9544-9553
65. Naruse Y., et al. Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13691-13696
66. Huang Y., et al. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nat. Neurosci. 2 (1999) 867-872
67. Hakimi M.A., et al. A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 7420-7425
68. Kleefstra T., et al. Disruption of the gene euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J. Med. Genet. 42 (2005) 299-306
69. Roopra A., et al. Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. Mol. Cell 14 (2004) 727-738
70. Wynder C., et al. Recruitment of MLL by HMG-domain protein iBRAF promotes neural differentiation. Nat. Cell Biol. 7 (2005) 1113-1117
71. McCampbell A., et al. Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 15179-15184
72. Hughes R.E., and Olson J.M. Therapeutic opportunities in polyglutamine disease. Nat. Med. 7 (2001) 419-423
73. Shimohata T., et al. Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases. Neuropathology 20 (2000) 326-333
74. Lin X., et al. Expanding our understanding of polyglutamine diseases through mouse models. Neuron 24 (1999) 499-502
75. Ferrante R.J., et al. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 23 (2003) 9418-9427
76. Butler R., and Bates G.P. Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat. Rev. Neurosci. 7 (2006) 784-796
77. Kariya S., et al. Cytoprotective effect of novel histone deacetylase inhibitors against polyglutamine toxicity. Neurosci. Lett. 392 (2006) 213-215
78. Hauser S.L., and Oksenberg J.R. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52 (2006) 61-76
79. Camelo S., et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J. Neuroimmunol. 164 (2005) 10-21
80. Ren M., et al. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J. Neurochem. 89 (2004) 1358-1367
81. Faraco G., et al. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol. Pharmacol. 70 (2006) 1876-1884
82. Schroeder F.A., et al. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol. Psychiatry 62 (2007) 55-64
83. Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol. Psychiatry 51 (2002) 775-787
84. Hahnen E., et al. In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J. Neurochem. 98 (2006) 193-202
85. Riessland M., et al. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells. Hum. Genet. 120 (2006) 101-110
86. Chen Y., et al. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res. 30 (2002) 2930-2939
87. Scarpa S., et al. Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. J. Alzheimers Dis. 9 (2006) 407-414
88. Sigalotti L., et al. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. J. Cell. Physiol. 212 (2007) 330-344
89. Langley B., et al. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 41-50
90. Saha R.N., and Pahan K. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ. 13 (2006) 539-550
91. Sadri-Vakili G., and Cha J.H. Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death). Curr. Alzheimer Res. 3 (2006) 403-408
92. Roth S.Y., et al. Histone acetyltransferases. Annu. Rev. Biochem. 70 (2001) 81-120
93. Marks P.A., et al. Histone deacetylases. Curr. Opin. Pharmacol. 3 (2003) 344-351
94. Trievel R.C. Structure and function of histone methyltransferases. Crit. Rev. Eukaryot. Gene Expr. 14 (2004) 147-169
95. Klose R.J., et al. JmjC-domain-containing proteins and histone demethylation. Nat. Rev. Genet. 7 (2006) 715-727
96. Millar C.B., and Grunstein M. Genome-wide patterns of histone modifications in yeast. Nat. Rev. Mol. Cell Biol. 7 (2006) 657-666
97. Althaus F.R., et al. Histone shuttling by poly ADP-ribosylation. Mol. Cell. Biochem. 138 (1994) 53-59
98. Loury R., and Sassone-Corsi P. Analysis of histone phosphorylation: coupling intracellular signaling to chromatin remodeling. Methods Enzymol. 377 (2004) 197-212
99. Zhang Y. Transcriptional regulation by histone ubiquitination and deubiquitination. Genes Dev. 17 (2003) 2733-2740
100. Shiio Y., and Eisenman R.N. Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13225-13230
101. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
102. Li Y., et al. Does heterochromatin protein 1 always follow code?. Proc. Natl. Acad. Sci. U. S. A. 99 Suppl 4 (2002) 16462-16469
103. Turner B.M. Cellular memory and the histone code. Cell 111 (2002) 285-291
104. Dion M.F., et al. Genomic characterization reveals a simple histone H4 acetylation code. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5501-5506
105. Vakoc C.R., et al. A profile of histone lysine methylation across transcribed mammalian chromatin. Mol. Cell. Biol. 26 (2006) 9185-9195
106. Kaneda M., et al. Role of de novo DNA methyltransferases in initiation of genomic imprinting and X-chromosome inactivation. Cold Spring Harb. Symp. Quant. Biol. 69 (2004) 125-129
107. Barreto G., et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445 (2007) 671-675